CIK: 0001807489 · Show all filings
Period: Q3 2023 (← Previous) (Next →)
Filing Date: Nov 13, 2023
Total Value ($000): $87,204 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| WVE | WAVE LIFE SCIENCES LTD | 7,044,500 | $40,506 | 46.4% | $3.31 | +38.0% | SHS | Y95308105 |
| IVVD | INVIVYD INC | 9,248,250 | $15,722 | 18.0% | $17.64 | -91.0% | COM | 00534A102 |
| RCKT | ROCKET PHARMACEUTICALS INC | 523,280 | $10,722 | 12.3% | $23.75 | -23.5% | COM | 77313F106 |
| — | SPRINGWORKS THERAPEUTICS INC | 197,700 | $4,571 | 5.2% | $25.89 | — | COM | 85205L107 |
| SLN | SILENCE THERAPEUTICS PLC | 363,800 | $3,573 | 4.1% | $9.41 | — | ADS | 82686Q101 |
| BBIO | BRIDGEBIO PHARMA INC | 121,200 | $3,196 | 3.7% | $39.38 | -27.9% | COM | 10806X102 |
| CRIS | CURIS INC | 421,951 | $2,781 | 3.2% | $12.87 | 0.0% | COM NEW | 231269309 |
| PRQR | PROQR THRAPEUTICS N V | 1,910,600 | $2,484 | 2.8% | $2.38 | -33.9% | SHS EURO | N71542109 |
| ARWR | ARROWHEAD PHARMACEUTICALS IN | 67,400 | $1,811 | 2.1% | $33.13 | -7.5% | COM | 04280A100 |
| TGTX | TG THERAPEUTICS INC | 216,600 | $1,811 | 2.1% | $15.49 | -10.0% | COM | 88322Q108 |
| — | NEXIMMUNE INC | 133,442 | $28 | 0.0% | $4.61 | — | COM | 65344D109 |